Literature DB >> 20940169

Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease.

Nobuyuki Itoh1, David M Ornitz.   

Abstract

Fibroblast growth factors (FGFs) are a family of structurally related polypeptides that are essential for embryonic development and that function postnatally as homoeostatic factors, in the response to injury, in the regulation of electrical excitability of cells and as hormones that regulate metabolism. In humans, FGF signalling is involved in developmental, neoplastic, metabolic and neurological diseases. Fgfs have been identified in metazoans but not in unicellular organisms. In vertebrates, FGFs can be classified as having intracrine, paracrine and endocrine functions. Paracrine and endocrine FGFs act via cell-surface FGF receptors (FGFRs); while, intracrine FGFs act independent of FGFRs. The evolutionary history of the Fgf family indicates that an intracrine Fgf is the likely ancestor of the Fgf family. During metazoan evolution, the Fgf family expanded in two phases, after the separation of protostomes and deuterostomes and in the evolution of early vertebrates. These expansions enabled FGFs to acquire diverse actions and functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940169      PMCID: PMC3106964          DOI: 10.1093/jb/mvq121

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  99 in total

1.  Purification of the fibroblast growth factor activity from bovine brain.

Authors:  D Gospodarowicz; H Bialecki; G Greenburg
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

2.  Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c.

Authors:  Shigeki Ohmachi; Tadahisa Mikami; Morichika Konishi; Ayumi Miyake; Nobuyuki Itoh
Journal:  J Neurosci Res       Date:  2003-05-15       Impact factor: 4.164

3.  Requirement of FGF-4 for postimplantation mouse development.

Authors:  B Feldman; W Poueymirou; V E Papaioannou; T M DeChiara; M Goldfarb
Journal:  Science       Date:  1995-01-13       Impact factor: 47.728

4.  Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.

Authors:  Stacey L House; Craig Bolte; Ming Zhou; Thomas Doetschman; Raisa Klevitsky; Gilbert Newman; Jo El J Schultz
Journal:  Circulation       Date:  2003-12-01       Impact factor: 29.690

5.  Secretion of FGF-16 requires an uncleaved bipartite signal sequence.

Authors:  Kazuko Miyakawa; Toru Imamura
Journal:  J Biol Chem       Date:  2003-07-08       Impact factor: 5.157

6.  Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

Authors:  Tobias Larsson; Ulf Nisbeth; Osten Ljunggren; Harald Jüppner; Kenneth B Jonsson
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

7.  FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations.

Authors:  J M Hébert; T Rosenquist; J Götz; G R Martin
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

8.  Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.

Authors:  Takashi Shimada; Makoto Kakitani; Yuji Yamazaki; Hisashi Hasegawa; Yasuhiro Takeuchi; Toshiro Fujita; Seiji Fukumoto; Kazuma Tomizuka; Takeyoshi Yamashita
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

9.  Requirements for FGF3 and FGF10 during inner ear formation.

Authors:  Yolanda Alvarez; Maria Teresa Alonso; Victor Vendrell; Laura Cecilia Zelarayan; Pablo Chamero; Thomas Theil; Michael R Bösl; Shigeaki Kato; Mark Maconochie; Dieter Riethmacher; Thomas Schimmang
Journal:  Development       Date:  2003-12       Impact factor: 6.868

10.  Mice homozygous for a targeted disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear.

Authors:  S L Mansour; J M Goddard; M R Capecchi
Journal:  Development       Date:  1993-01       Impact factor: 6.868

View more
  255 in total

1.  Fibroblast growth factor-12 (FGF12) translocation into intestinal epithelial cells is dependent on a novel cell-penetrating peptide domain: involvement of internalization in the in vivo role of exogenous FGF12.

Authors:  Fumiaki Nakayama; Takeshi Yasuda; Sachiko Umeda; Masahiro Asada; Toru Imamura; Viktor Meineke; Makoto Akashi
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  FGF23 and PTH--double agents at the heart of CKD.

Authors:  Justin Silver; Mariano Rodriguez; Eduardo Slatopolsky
Journal:  Nephrol Dial Transplant       Date:  2012-03-23       Impact factor: 5.992

Review 3.  Voltage-gated sodium channel-associated proteins and alternative mechanisms of inactivation and block.

Authors:  Mitchell Goldfarb
Journal:  Cell Mol Life Sci       Date:  2011-09-27       Impact factor: 9.261

4.  Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor.

Authors:  Regina Goetz; Mutsuko Ohnishi; Serkan Kir; Hiroshi Kurosu; Lei Wang; Johanne Pastor; Jinghong Ma; Weiming Gai; Makoto Kuro-o; Mohammed S Razzaque; Moosa Mohammadi
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

Review 5.  Primary cilia and coordination of receptor tyrosine kinase (RTK) signalling.

Authors:  Søren T Christensen; Christian A Clement; Peter Satir; Lotte B Pedersen
Journal:  J Pathol       Date:  2011-11-21       Impact factor: 7.996

6.  Unliganded fibroblast growth factor receptor 1 forms density-independent dimers.

Authors:  Laëtitia Comps-Agrar; Diana Ronai Dunshee; Dan L Eaton; Junichiro Sonoda
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

Review 7.  Muscle-invasive urothelial bladder cancer: an update on systemic therapy.

Authors:  Hayley Knollman; J Luke Godwin; Rishi Jain; Yu-Ning Wong; Elizabeth R Plimack; Daniel M Geynisman
Journal:  Ther Adv Urol       Date:  2015-12

8.  Probing the role of proline -135 on the structure, stability, and cell proliferation activity of human acidic fibroblast growth factor.

Authors:  Julie Eberle Davis; Arwa Alghanmi; Ravi Kumar Gundampati; Srinivas Jayanthi; Ellen Fields; Monica Armstrong; Vanessa Weidling; Varun Shah; Shilpi Agrawal; Bhanu Prasanth Koppolu; David A Zaharoff; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  Arch Biochem Biophys       Date:  2018-07-19       Impact factor: 4.013

9.  C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesis.

Authors:  Zhuo Chen; Lin-Jiang Tong; Bai-You Tang; Hong-Yan Liu; Xin Wang; Tao Zhang; Xian-Wen Cao; Yi Chen; Hong-Lin Li; Xu-Hong Qian; Yu-Fang Xu; Hua Xie; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2018-11-28       Impact factor: 6.150

Review 10.  Cell signaling pathways in vertebrate lens regeneration.

Authors:  Jonathan J Henry; Alvin G Thomas; Paul W Hamilton; Lisa Moore; Kimberly J Perry
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.